iZafe Group AB (OSTO:IZAFE B) 3-Year Share Buyback Ratio : -57.20% (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is iZafe Group AB 3-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

3-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past three years. It is calculated as the annualized percentage change in shares outstanding from three years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. iZafe Group AB's current 3-Year Share Buyback Ratio was -57.20%.

The historical rank and industry rank for iZafe Group AB's 3-Year Share Buyback Ratio or its related term are showing as below:

OSTO:IZAFE B' s 3-Year Share Buyback Ratio Range Over the Past 10 Years
Min: -91.9 Med: -29.45 Max: -4.8
Current: -57.2

During the past 13 years, iZafe Group AB's highest 3-Year Share Buyback Ratio was -4.80%. The lowest was -91.90%. And the median was -29.45%.

OSTO:IZAFE B's 3-Year Share Buyback Ratio is ranked worse than
91.28% of 642 companies
in the Medical Devices & Instruments industry
Industry Median: -2.9 vs OSTO:IZAFE B: -57.20

Competitive Comparison of iZafe Group AB's 3-Year Share Buyback Ratio

For the Medical Instruments & Supplies subindustry, iZafe Group AB's 3-Year Share Buyback Ratio, along with its competitors' market caps and 3-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

iZafe Group AB's 3-Year Share Buyback Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's 3-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's 3-Year Share Buyback Ratio falls into.

Save Embed

;

Save Embed

;

iZafe Group AB 3-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from three years ago to the current year. The annualized percentage change is calculated with expontential compound based on the latest four years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

iZafe Group AB (OSTO:IZAFE B) 3-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

iZafe Group AB 3-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of iZafe Group AB's 3-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

iZafe Group AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iZafe Group AB (OSTO:IZAFE B) » Definitions » 3-Year Share Buyback Ratio

Comparable Companies

Traded in Other Exchanges

M02:Germany

Address

David Bagares Gata 3, Stockholm, SWE, 111 38

Website

https://www.izafe.se

iZafe Group AB is a pure Life-Science company engaged in the development of digital drug dispensing. The company conducts research, development and marketing of digital medical solutions and services for safer drug management at home. iZafe's drug robot Dosell is used to reduce the risk of incorrect medication at home, relieve public care, increase the patient's quality of life and create a safer environment for relatives. The customers consist of public and private care providers in Sweden, the Nordic countries and globally. iZafe sells through well-established partners who already have long and deep customer relationships with the priority customer groups.

iZafe Group AB Headlines

No Headlines